MERTK and non-small cell lung carcinoma: In addition, many NSCLC lose p53 entirely leading to the unavailability of p53 to promote Mer expression [30], therefore, other unappreciated mechanisms for Mer overexpression would be operative in these tumors which remains to be explored.